Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$4.82 - $6.93 $173 - $249
36 Added 276.92%
49 $251,000
Q4 2023

Jun 26, 2024

SELL
$5.63 - $8.27 $202 - $297
-36 Reduced 73.47%
13 $87,000
Q3 2023

Nov 15, 2023

BUY
$6.71 - $11.83 $13 - $23
2 Added 18.18%
13 $0
Q2 2023

Aug 08, 2023

SELL
$11.12 - $22.2 $100 - $199
-9 Reduced 45.0%
11 $650,000
Q1 2023

May 12, 2023

SELL
$18.7 - $23.07 $56 - $69
-3 Reduced 13.04%
20 $266,000
Q4 2022

Feb 15, 2023

SELL
$18.12 - $27.32 $1,304 - $1,967
-72 Reduced 75.79%
23 $2.09 Million
Q2 2022

Aug 05, 2022

SELL
$13.15 - $20.45 $4,431 - $6,891
-337 Reduced 78.01%
95 $242,000
Q1 2022

May 13, 2022

SELL
$14.54 - $21.5 $3,794 - $5,611
-261 Reduced 37.66%
432 $2.47 Million
Q4 2021

Feb 11, 2022

BUY
$20.24 - $36.01 $10,241 - $18,221
506 Added 270.59%
693 $3.33 Million
Q3 2021

Nov 12, 2021

SELL
$26.01 - $38.22 $338 - $496
-13 Reduced 6.5%
187 $32,000
Q2 2021

Aug 11, 2021

BUY
$29.97 - $37.17 $629 - $780
21 Added 11.73%
200 $31,000
Q1 2021

May 17, 2021

SELL
$29.24 - $42.03 $146 - $210
-5 Reduced 2.72%
179 $6.03 Million
Q4 2020

Feb 16, 2021

BUY
$35.35 - $50.67 $6,504 - $9,323
184 New
184 $6,000
Q2 2020

Aug 13, 2020

SELL
$45.06 - $67.74 $63,129 - $94,903
-1,401 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$40.01 - $73.97 $21,525 - $39,795
-538 Reduced 27.75%
1,401 $66,000
Q4 2019

Feb 28, 2020

BUY
$37.13 - $74.62 $11,436 - $22,982
308 Added 18.88%
1,939 $72,000
Q3 2019

Oct 15, 2019

SELL
$39.36 - $76.8 $16,413 - $32,025
-417 Reduced 20.36%
1,631 $64,000
Q2 2019

Jul 26, 2019

SELL
$52.76 - $82.19 $26,432 - $41,177
-501 Reduced 19.65%
2,048 $160,000
Q1 2019

Apr 19, 2019

SELL
$27.39 - $68.41 $166,832 - $416,685
-6,091 Reduced 70.5%
2,549 $153,000
Q3 2018

Oct 31, 2018

BUY
$29.75 - $43.08 $24,038 - $34,808
808 Added 10.32%
8,640 $214,000
Q2 2018

Aug 14, 2018

BUY
$21.96 - $39.94 $43,480 - $79,081
1,980 Added 33.83%
7,832 $277,000
Q1 2018

May 23, 2018

BUY
$17.1 - $26.61 $100,069 - $155,721
5,852 New
5,852 $177,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.